Development of an alpha-conotoxin rgia analog as a novel, non-opioid therapeutic for chronic neuropathic pain

Ended Project Grant Awarded Last action

Award ID
R43DA045413
Recipient
Awarding agency
Obligated
$225,000

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Place of performance
Seattle, WA 98109, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Original award $225,000

Quick answers

Who received award R43DA045413?

R43DA045413 was awarded to Kineta Inc. by National Institute on Drug Abuse (National Institutes of Health) on January 15, 2018.

How much is award R43DA045413 worth?

$225,000 has been obligated on R43DA045413.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award